A glycobiology review: carbohydrates, lectins and implications in cancer therapeutics.

This review is intended for general readers who would like a basic foundation in carbohydrate structure and function, lectin biology, and the implications of glycobiology in human health and disease, particularly in cancer therapeutics. These topics are among the hundreds included in the field of glycobiology and are treated here because they form the cornerstone of glycobiology or the focus of many advances in this rapidly expanding field.

[1]  G. Ruiz-Palacios,et al.  Human milk glycans protect infants against enteric pathogens. , 2005, Annual review of nutrition.

[2]  S. Barondes,et al.  Galectins. Structure and function of a large family of animal lectins. , 1994, The Journal of biological chemistry.

[3]  E. Gorelik,et al.  Mechanisms of Cytotoxic Activity of Lectins , 1994 .

[4]  Nathan Sharon,et al.  Carbohydrates and glycoconjugates: progress in non-mammalian glycosylation, glycosyltransferases, invertebrate lectins and carbohydrate-carbohydrate interactions. , 2004, Current opinion in structural biology.

[5]  S. Oppenheimer,et al.  Microbead analysis of cell binding to immobilized lectin: an alternative to microarrays in the development of carbohydrate drugs and diagnostic tests. , 2006, Acta histochemica.

[6]  T. Pokka,et al.  Randomised trial of cranberry-lingonberry juice and Lactobacillus GG drink for the prevention of urinary tract infections in women , 2001, BMJ : British Medical Journal.

[7]  W. Weis,et al.  The C‐type lectin superfamily in the immune system , 1998, Immunological reviews.

[8]  J. Hanover.  Glycan‐dependent signaling: O‐linked N‐acetylglucosamine , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  Effect of honey on the common cold. , 2009, Archives of medical research.

[10]  T. Minko.  Drug targeting to the colon with lectins and neoglycoconjugates. , 2004, Advanced drug delivery reviews.

[11]  L. Stoolman.  Adhesion molecules controlling lymphocyte migration , 1989, Cell.

[12]  Donald Voet,et al.  Fundamentals of Biochemistry , 1999 .

[13]  J. Vliegenthart.  Carbohydrate based vaccines , 2006, FEBS letters.

[14]  Mariano J. Alvarez,et al.  Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege. , 2004, Cancer cell.

[15]  J. Churey,et al.  Antimicrobial activity of bacterial isolates from different floral sources of honey. , 2008, International journal of food microbiology.

[16]  J. Kjaergaard,et al.  Tumor infiltration by adoptively transferred T cells is independent of immunologic specificity but requires down-regulation of L-selectin expression. , 1999, Journal of immunology.

[17]  Gordon D. Brown,et al.  C-type lectins and phagocytosis , 2009, Immunobiology.

[18]  A. Varki,et al.  Selectin ligands. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Maureen E. Taylor,et al.  Introduction to glycobiology , 2003 .

[20]  R. Lechler,et al.  Galectin-1: a key effector of regulation mediated by CD4+CD25+ T cells. , 2007, Blood.

[21]  H. Sytwu,et al.  Attenuation of Th1 response through galectin‐9 and T‐cell Ig mucin 3 interaction inhibits autoimmune diabetes in NOD mice , 2009, European journal of immunology.

[22]  M. Taylor,et al.  Biology of animal lectins. , 1993, Annual review of cell biology.

[23]  R. Brentani,et al.  Asn-linked oligosaccharide-dependent interaction between laminin and gp120/140. An alpha 6/beta 1 integrin. , 1991, The Journal of biological chemistry.

[24]  M. Fukuda.  Cell Surface Carbohydrates and Cell Development , 1991 .

[25]  Nathan Sharon,et al.  Carbohydrates as future anti-adhesion drugs for infectious diseases. , 2006, Biochimica et biophysica acta.

[26]  S. Thiel,et al.  Mannan‐binding lectin deficiency modulates the humoral immune response dependent on the genetic environment , 2009, Immunology.

[27]  J. Dennis,et al.  Beta 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. , 1991, Cancer research.

[28]  H. Inohara,et al.  Functional evidence that cell surface galectin-3 mediates homotypic cell adhesion. , 1995, Cancer research.

[29]  P. Gullino,et al.  Angiogenesis can be stimulated or repressed in vivo by a change in GM3:GD3 ganglioside ratio. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[30]  I. Fichtner,et al.  Lipoplexes with alkylphospholipid as new helper lipid for efficient in vitro and in vivo gene transfer in tumor therapy , 2003, Cancer Gene Therapy.

[31]  S. Hakomori,et al.  Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. , 1989, Advances in cancer research.

[32]  S. Oppenheimer,et al.  Carbohydrate-based experimental therapeutics for cancer, HIV/AIDS and other diseases. , 2008, Acta histochemica.

[33]  Carla Danussi,et al.  A newly generated functional antibody identifies Tn antigen as a novel determinant in the cancer cell–lymphatic endothelium interaction , 2009, Glycobiology.

[34]  R. Yu,et al.  Suppression of ganglioside GD3 expression in a rat F-11 tumor cell line reduces tumor growth, angiogenesis, and vascular endothelial growth factor production. , 2000, Cancer research.

[35]  Nir Dotan,et al.  Intact cell adhesion to glycan microarrays. , 2003, Glycobiology.

[36]  S. Hakomori.  Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. , 1996, Cancer research.

[37]  G. Pilkington,et al.  Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. , 1996, Cancer letters.

[38]  P. Stahl,et al.  The mannose receptor is a pattern recognition receptor involved in host defense. , 1998, Current opinion in immunology.

[39]  T. Paavonen,et al.  Endothelial and epithelial expression of sialyl Lewisx and sialyl Lewisa in lesions of breast carcinoma , 1997, International journal of cancer.

[40]  C. E. Warren,et al.  Modeling a congenital disorder of glycosylation type I in C. elegans: a genome-wide RNAi screen for N-glycosylation-dependent loci. , 2009, Glycobiology.

[41]  K. Joiner,et al.  Human mannose-binding protein activates the alternative complement pathway and enhances serum bactericidal activity on a mannose-rich isolate of Salmonella. , 1989, The Journal of clinical investigation.

[42]  J. W. Dennis,et al.  N-linked oligosaccharide processing and tumor cell biology. , 1991, Seminars in cancer biology.

[43]  Eileen L. Heinrich,et al.  Direct targeting of cancer cells: a multiparameter approach. , 2005, Acta histochemica.

[44]  M. Ohue,et al.  Unusual accumulation of sulfated glycosphingolipids in colon cancer cells. , 2009, Glycobiology.

[45]  E. Berger,et al.  Localization of three human polypeptide GalNAc-transferases in HeLa cells suggests initiation of O-linked glycosylation throughout the Golgi apparatus. , 1998, Journal of cell science.

[46]  M. Toyota,et al.  DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer. , 2008, Gastroenterology.

[47]  Riyao Yang,et al.  Expression of galectin-3 modulates T-cell growth and apoptosis. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[48]  G. Gibson,et al.  Sialyloligosaccharides inhibit cholera toxin binding to the GM1 receptor. , 2008, Carbohydrate research.

[49]  M. Disney,et al.  The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens. , 2004, Chemistry & biology.

[50]  M. Fukuda,et al.  Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. , 1997, Cancer research.

[51]  G. Rabinovich,et al.  Functions of cell surface galectin-glycoprotein lattices. , 2007, Current opinion in structural biology.

[52]  Pablo Engel,et al.  The selecting: vascular adhesion molecules , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  L. Baum,et al.  Galectin-1, an Endogenous Lectin Produced by Thymic Epithelial Cells, Induces Apoptosis of Human Thymocytes , 1997, The Journal of experimental medicine.

[54]  Z. Lu,et al.  Water soluble polymers in tumor targeted delivery. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[55]  R. Barthelson,et al.  Adherence of Streptococcus pneumoniae to Respiratory Epithelial Cells Is Inhibited by Sialylated Oligosaccharides , 1998, Infection and Immunity.

[56]  Rohit R. Ghurye,et al.  Galectin-1 stimulates monocyte chemotaxis via the p44/42 MAP kinase pathway and a pertussis toxin-sensitive pathway. , 2009, Glycobiology.

[57]  Gerald W. Hart,et al.  Cycling of O-linked β-N-acetylglucosamine on nucleocytoplasmic proteins , 2007, Nature.

[58]  K. Claffey,et al.  Gangliosides influence angiogenesis in an experimental mouse brain tumor. , 1999, Cancer research.

[59]  Howard J. Allen,et al.  Glycoconjugates : composition, structure, and function , 1992 .

[60]  Maria Trulsson,et al.  alpha-Lactalbumin, engineered to be nonnative and inactive, kills tumor cells when in complex with oleic acid: a new biological function resulting from partial unfolding. , 2009, Journal of molecular biology.

[61]  A. Kumar,et al.  Developmental regulation, expression, and apoptotic potential of galectin-9, a beta-galactoside binding lectin. , 1997, The Journal of clinical investigation.

[62]  D. Tweardy,et al.  Lectin-induced apoptosis of tumour cells. , 1993, Glycobiology.

[63]  L. Banner,et al.  Lectin binding and effects in culture on human cancer and non-cancer cell lines: examination of issues of interest in drug design strategies. , 2007, Acta histochemica.

[64]  A. Raz,et al.  On the Role of Cell Surface Carbohydrates and their Binding Proteins (lectins) in Tumor Metastasis , 2004, Cancer and Metastasis Reviews.

[65]  C. Van Steenkiste,et al.  Alteration of protein glycosylation in liver diseases. , 2009, Journal of hepatology.

[66]  David A. Russell,et al.  Bacterial detection using carbohydrate-functionalised CdS quantum dots: a model study exploiting E. coli recognition of mannosides , 2009 .

[67]  K. Karlsson.  Meaning and therapeutic potential of microbial recognition of host glycoconjugates , 1998, Molecular microbiology.

[68]  R. Lotan,et al.  Expression of galectins in head and neck squamous cell carcinoma , 1996, Head & neck.

[69]  J. Dennis,et al.  Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. , 1989, Oncogene.

[70]  V. Sinha,et al.  Polysaccharides in colon-specific drug delivery. , 2001, International journal of pharmaceutics.

[71]  M. Kyogashima,et al.  Escherichia coli K99 binds to N-glycolylsialoparagloboside and N-glycolyl-GM3 found in piglet small intestine. , 1989, Archives of biochemistry and biophysics.

[72]  K. Joiner,et al.  The human mannose-binding protein functions as an opsonin , 1989, The Journal of experimental medicine.

[73]  R. Dwek,et al.  Exploiting the defensive sugars of HIV-1 for drug and vaccine design , 2007, Nature.

[74]  P. Schlesinger,et al.  Receptor-mediated pinocytosis of mannose glycoconjugates by macrophages: Characterization and evidence for receptor recycling , 1980, Cell.

[75]  S. Head,et al.  Detection of differentially expressed wound-healing-related glycogenes in galectin-3-deficient mice. , 2009, Investigative ophthalmology & visual science.

[76]  Z. Lu,et al.  HPMA copolymer-anticancer drug conjugates: design, activity, and mechanism of action. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[77]  S. Oppenheimer.  Cellular basis of cancer metastasis: A review of fundamentals and new advances. , 2006, Acta histochemica.

[78]  N. Sharon,et al.  Anti-adhesion therapy of bacterial diseases: prospects and problems. , 2003, FEMS immunology and medical microbiology.

[79]  T. Orntoft,et al.  Clinical aspects of altered glycosylation of glycoproteins in cancer , 1999, Electrophoresis.

[80]  N. Sharon,et al.  Safe as mother's milk: Carbohydrates as future anti-adhesion drugs for bacterial diseases , 2000, Glycoconjugate Journal.

[81]  R. Bresalier,et al.  Expression of an endogenous galactose‐binding lectin correlates with neoplastic progression in the colon , 1995, Cancer.

[82]  S. Hakomori,et al.  Correlation of expression of H/Le(y)/Le(b) antigens with survival in patients with carcinoma of the lung. , 1992, The New England journal of medicine.

[83]  G. Ragupathi.  Carbohydrate antigens as targets for active specific immunotherapy , 1996, Cancer Immunology, Immunotherapy.

[84]  M. Fukuda.  Possible roles of tumor-associated carbohydrate antigens. , 1996, Cancer research.

[85]  P. Hitchen,et al.  Targeted glycoproteomic identification of cancer cell glycosylation , 2009, Glycobiology.

[86]  Barbara Mulloy,et al.  Carbohydrates and glycoconjugates. Glycomics: the new era of carbohydrate biology. , 2003, Current opinion in structural biology.

[87]  Y. Kozutsumi,et al.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[88]  Yehia Mechref,et al.  Glycomic profiling of invasive and non-invasive breast cancer cells , 2009, Glycoconjugate Journal.

[89]  J. Dennis,et al.  N-Acetylglucosaminyltransferase V (Mgat5)-Mediated N-Glycosylation Negatively Regulates Th1 Cytokine Production by T Cells1 , 2004, The Journal of Immunology.

[90]  K. Hartshorn,et al.  Enhanced Antiviral and Opsonic Activity of a Human Mannose-Binding Lectin and Surfactant Protein D Chimera1 , 2000, The Journal of Immunology.

[91]  R. Kerbel,et al.  Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. , 1987, Science.

[92]  Zhongshan Wang,et al.  Overexpression of fucosyltransferase VII (FUT7) promotes embryo adhesion and implantation. , 2009, Fertility and sterility.

[93]  C. Kensil,et al.  Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex. , 1991, Journal of immunology.

[94]  I. Ofek,et al.  Bacterial adhesion to animal cells and tissues , 2003 .

[95]  A. Dell,et al.  Fut2-null mice display an altered glycosylation profile and impaired BabA-mediated Helicobacter pylori adhesion to gastric mucosa. , 2009, Glycobiology.

[96]  P. Seeberger,et al.  Recent advances in carbohydrate-based vaccines. , 2009, Current opinion in chemical biology.

[97]  R. Bast,et al.  Differential expression of the 67-kD laminin receptor and 31-kD human laminin-binding protein in human ovarian carcinomas. , 1994, European journal of cancer.

[98]  R. Bast,et al.  Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. , 1996, Human pathology.

[99]  S. Barondes,et al.  God must love galectins; he made so many of them. , 1999, Glycobiology.

[100]  J. Hacker,et al.  Receptor Structure for F1C Fimbriae of Uropathogenic Escherichia coli , 2000, Infection and Immunity.

[101]  V. Castronovo,et al.  DECREASED EXPRESSION OF GALECTIN‐3 IS ASSOCIATED WITH PROGRESSION OF HUMAN BREAST CANCER , 1996, The Journal of pathology.

[102]  Michael S. Cohen,et al.  Molecular Basis for the Enterocyte Tropism Exhibited bySalmonella typhimurium Type 1 Fimbriae* , 1999, The Journal of Biological Chemistry.

[103]  A. Raz,et al.  Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. , 1992, Journal of the National Cancer Institute.

[104]  Avadhesha Surolia,et al.  N-linked oligosaccharides as outfitters for glycoprotein folding, form and function. , 2006, Trends in biochemical sciences.

[105]  J. Dennis,et al.  Asn-linked oligosaccharides in lectin-resistant tumor-cell mutants with varying metastatic potential. , 1986, European journal of biochemistry.

[106]  T. Gallagher,et al.  O-glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines. , 2009, Glycobiology.

[107]  U. Schumacher,et al.  Influence of mistletoe lectins and cytokines induced by them on cell proliferation of human melanoma cells in vitro. , 2005, Toxicology.

[108]  A. Kobata,et al.  Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. , 1985, The Journal of biological chemistry.

[109]  Lode Wyns,et al.  Receptor binding studies disclose a novel class of high‐affinity inhibitors of the Escherichia coli FimH adhesin , 2004, Molecular microbiology.

[110]  K. Drickamer.  Increasing diversity of animal lectin structures. , 1995, Current opinion in structural biology.

[111]  T. Irimura,et al.  Colorectal cancer metastasis determined by carbohydrate-mediated cell adhesion: role of sialyl-LeX antigens. , 1993, Seminars in cancer biology.

[112]  J. Dennis,et al.  Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation , 2001, Nature.

[113]  D. Gin,et al.  Chemical glycosylation in the synthesis of glycoconjugate antitumour vaccines , 2007, Nature.

[114]  N. Sharon,et al.  History of lectins: from hemagglutinins to biological recognition molecules. , 2004, Glycobiology.

[115]  M. Wirth,et al.  Alteration of the glycosylation pattern of monocytic THP-1 cells upon differentiation and its impact on lectin-mediated drug delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[116]  K. Yamada,et al.  Analysis of the role of glycosylation of the human fibronectin receptor. , 1989, The Journal of biological chemistry.

[117]  T. Sasaki,et al.  Regulatory role of GM3 ganglioside in alpha 5 beta 1 integrin receptor for fibronectin-mediated adhesion of FUA169 cells. , 1993, The Journal of biological chemistry.

[118]  Lode Wyns,et al.  The fimbrial adhesin F17‐G of enterotoxigenic Escherichia coli has an immunoglobulin‐like lectin domain that binds N‐acetylglucosamine , 2003, Molecular microbiology.

[119]  G. Karp.  Cell and molecular biology : concepts and experiments / Gerald Karp , 1996 .

[120]  J. Petit,et al.  Glycoprotein glycans that inhibit adhesion of Escherichia coli mediated by K99 fimbriae: treatment of experimental colibacillosis , 1990, Infection and immunity.

[121]  Xi Jiang,et al.  Human-milk glycans that inhibit pathogen binding protect breast-feeding infants against infectious diarrhea. , 2005, The Journal of nutrition.

[122]  L. Estevinho,et al.  Antioxidant activity of Portuguese honey samples: Different contributions of the entire honey and phenolic extract , 2009 .

[123]  R. Mody,et al.  Use of lectins as diagnostic and therapeutic tools for cancer. , 1995, Journal of pharmacological and toxicological methods.

[124]  K. Pienta,et al.  Galectin-3 induces endothelial cell morphogenesis and angiogenesis. , 2000, The American journal of pathology.

[125]  F. Guarner,et al.  Gut flora in health and disease , 2003, The Lancet.

[126]  G. Rabinovich.  Galectins: an evolutionarily conserved family of animal lectins with multifunctional properties; a trip from the gene to clinical therapy , 1999, Cell Death and Differentiation.

[127]  Y. Kato,et al.  Deletion polymorphism of SIGLEC14 and its functional implications. , 2009, Glycobiology.

[128]  J. Fell.  Targeting of drugs and delivery systems to specific sites in the gastrointestinal tract. , 1996, Journal of anatomy.

[129]  C. Lehr,et al.  Lectin-mediated drug targeting: history and applications. , 2004, Advanced drug delivery reviews.

[130]  N. Sharon,et al.  Lectins as cell recognition molecules. , 1989, Science.

[131]  D. Zopf,et al.  Oligosaccharide anti-infective agents , 1996, The Lancet.

[132]  Zheng-Rong Lu,et al.  Design of novel bioconjugates for targeted drug delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[133]  A. I. Ruiz-Matute,et al.  Volatile and carbohydrate composition of rare unifloral honeys from Spain , 2007 .

[134]  G. Hart,et al.  Cell signaling, the essential role of O-GlcNAc! , 2006, Biochimica et biophysica acta.

[135]  I. Suetake,et al.  Cyclin-dependent kinase-like 5 binds and phosphorylates DNA methyltransferase 1. , 2008, Biochemical and biophysical research communications.

[136]  T. Kawasaki,et al.  Serum lectin with known structure activates complement through the classical pathway. , 1987, The Journal of biological chemistry.

[137]  N. Sharon,et al.  Carbohydrates in cell recognition. , 1993, Scientific American.

[138]  C. Ponting,et al.  Concepts and principles of glycobiology , 1993, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[139]  U. Galili,et al.  Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody. , 2009, Vaccine.

[140]  Soonsil Hyun,et al.  Selection and syntheses of tentacle type peptides as 'artificial' lectins against various cell-surface carbohydrates. , 2007, Bioorganic & medicinal chemistry.

[141]  T. Irimura,et al.  Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study. , 1993, Cancer research.

[142]  S. Eichmüller,et al.  Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy? , 2008, Autoimmunity reviews.

[143]  C. Kelly,et al.  Anti-adhesive strategies in the prevention of infectious disease at mucosal surfaces , 2000, Expert opinion on investigational drugs.

[144]  H. Oettgen,et al.  GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21. , 1995, Cancer research.

[145]  R. Bresalier,et al.  Expression of the endogenous galactose‐binding protein galectin‐3 correlates with the malignant potential of tumors in the central nervous system , 1997, Cancer.

[146]  K. Ajesh,et al.  Peptide antibiotics: An alternative and effective antimicrobial strategy to circumvent fungal infections , 2009, Peptides.

[147]  C. Couldrey,et al.  Metastases: the glycan connection , 2000, Breast Cancer Research.

[148]  J. Arango,et al.  Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri- and tetraantennary glycopeptides containing [GlcNAc-beta (1,6)Man-alpha (1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. , 1986, The Journal of biological chemistry.

[149]  S. Hakomori,et al.  Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. , 1985, Cancer research.

[150]  Christian Becker,et al.  Human CD4+CD25+ regulatory T cells: proteome analysis identifies galectin-10 as a novel marker essential for their anergy and suppressive function. , 2007, Blood.

[151]  L. Baum,et al.  Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death , 1998, Journal of Molecular Medicine.

[152]  R. Yu,et al.  Alteration of ganglioside composition by stable transfection with antisense vectors against GD3-synthase gene expression. , 1999, Biochemistry.

[153]  H. Inohara,et al.  Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. , 1997, Cancer Research.

[154]  A. Rek,et al.  Therapeutically targeting protein–glycan interactions , 2009, British journal of pharmacology.

[155]  H. Kagamu,et al.  Purification of L-selectin(low) cells promotes the generation of highly potent CD4 antitumor effector T lymphocytes. , 1998, Journal of immunology.

[156]  Ajit Varki,et al.  Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins , 2007, Nature.

[157]  A. Tonevitsky,et al.  Immunotoxin with mistletoe lectin I A-chain and ricin A-chain directed against CD5 antigen of human T-lymphocytes; comparison of efficiency and specificity. , 1991, International journal of immunopharmacology.